ACURA PHARMS INC (ACUR) earnings
Quarterly and annual ACUR reports and results, each read against the price at its own news timestamp. Back to the ACUR overview →
12 measured ACUR earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form NT 10-K ACURA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | +0.00% | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form NT 10-K ACURA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | — | +0.00% | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | +0.00% | +17.71% | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form NT 10-K ACURA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | — | — |
Keep exploring
More ACUR: analyst actions → · SEC filings → · ACUR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| REPLICEL LIFE SCIENCE ORD (REPCF) | 59 | 0.00% | 27% |
| REALM THERAPEUTICS PLC ADS (RLM) | 59 | 0.00% | 41% |
| ONCOBIOLOGICS (ONS) | 58 | 0.00% | 47% |
| BESPOKE EXTRACTS INC (BSPK) | 57 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.